Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as a breakthrough therapy for obesity, overweight, and other associated health conditions, delivering unprecedented weight loss in clinical trials
MOTS-c is added at Week 5 with two common approaches: intermittent (most common) or low-dose daily
High costs, stigma, and limited provider familiarity often stand in the way
During power outages or refrigerator malfunctions, patients should contact their pharmacist or the medication manufacturer for guidance on temperature excursions
Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made
For a deeper understanding of how GLP-1 medications work and their timeline , research the specific mechanisms before your appointment
